Business Context and Reporting Period
This Form 8-K Current Report, dated August 30, 2021, details a material definitive agreement and listing transfer for Focus Universal Inc. (Nevada). The Company, previously quoted on the OTCQB Market, executed an underwritten public offering and commenced trading on The Nasdaq Capital Market under the symbol "FCUV" on August 31, 2021.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $11,500,000 from the sale of 2,300,000 shares of common stock.
- Offering Price: $5.00 per share.
- Underwriting Discount: 7% of gross proceeds.
- Over-Allotment: The offering included the full exercise of a 300,000 share over-allotment option.
- Warrants Issued: 161,000 warrants issued to the underwriter (7% of shares sold) with an exercise price of $6.25 and a five-year term.
- Use of Proceeds: R&D for Ubiquitor devices, manufacturing/assembly, marketing, and general working capital.
Note: This filing does not provide historical revenue, profit, cash flow, or debt metrics for the Company.
Material Changes
- Listing Status: Transferred from the OTCQB Market to The Nasdaq Capital Market.
- Capital Structure: Significant increase in outstanding shares due to the issuance of 2,300,000 new shares.
- Liquidity Event: Raised approximately $11.5 million in gross capital.
Guidance, Outlook, and Restrictions
- Lock-Up Agreements: Existing stockholders, directors, and executive officers are restricted from selling securities for 12 months following August 30, 2021.
- Issuance Moratorium: The Company agreed not to issue or announce the issuance of common stock or equivalents for 365 days, with limited exemptions.
- Warrant Restrictions: Underwriter's warrants are subject to a 180-day lock-up and are non-exercisable for the first six months.
- Strategic Focus: Management intends to focus on the development and commercialization of the Ubiquitor device for power line communications.
Investor Verification Checklist
- Verify the net proceeds after deducting the 7% underwriting discount and estimated offering expenses.
- Confirm the exact number of shares outstanding post-offering to assess dilution.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific representations and indemnification terms.
- Monitor the Company's ability to meet Nasdaq continued listing standards following the transfer.
- Assess the timeline and budget for the Ubiquitor device R&D and manufacturing plans outlined in the use of proceeds.